Key Takeaways
Adherence is one of pharma’s toughest challenges, especially in long-term allergy immunotherapy. This case study reveals how ALK leveraged the MyTherapy platform to turn patient education, behavioral insight, and data intelligence into measurable persistence and satisfaction outcomes.
In this case study, learn how to:
- Build a digital patient-support model that scales across markets
- Drive lasting 3-year treatment persistence through targeted education
- Translate engagement into actionable adherence insights for continuous improvement
Download the case study to see how ALK and smartpatient transformed digital education into measurable treatment impact!
